Febrile Neutropenia Risk Assessment Prior to Chemotherapy
-
Percentage of patients with a solid malignant tumor or lymphoma who had a febrile neutropenia (FN) risk assessment completed and documented in the medical record prior to the first cycle of intravenous chemotherapy
CBE ID2930